389 related articles for article (PubMed ID: 28570824)
1. Protein Epitope Mimetics: From New Antibiotics to Supramolecular Synthetic Vaccines.
Zerbe K; Moehle K; Robinson JA
Acc Chem Res; 2017 Jun; 50(6):1323-1331. PubMed ID: 28570824
[TBL] [Abstract][Full Text] [Related]
2. Max Bergmann lecture protein epitope mimetics in the age of structural vaccinology.
Robinson JA
J Pept Sci; 2013 Mar; 19(3):127-40. PubMed ID: 23349031
[TBL] [Abstract][Full Text] [Related]
3. Folded Synthetic Peptides and Other Molecules Targeting Outer Membrane Protein Complexes in Gram-Negative Bacteria.
Robinson JA
Front Chem; 2019; 7():45. PubMed ID: 30788339
[TBL] [Abstract][Full Text] [Related]
4. Design and applications of protein epitope mimetics.
Robinson JA
Chimia (Aarau); 2013; 67(12-13):885-90. PubMed ID: 24594332
[TBL] [Abstract][Full Text] [Related]
5. Beta-hairpin peptidomimetics: design, structures and biological activities.
Robinson JA
Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
[TBL] [Abstract][Full Text] [Related]
6. A Peptidomimetic Antibiotic Interacts with the Periplasmic Domain of LptD from Pseudomonas aeruginosa.
Andolina G; Bencze LC; Zerbe K; Müller M; Steinmann J; Kocherla H; Mondal M; Sobek J; Moehle K; Malojčić G; Wollscheid B; Robinson JA
ACS Chem Biol; 2018 Mar; 13(3):666-675. PubMed ID: 29359918
[TBL] [Abstract][Full Text] [Related]
7. Synthetic virus-like particles and conformationally constrained peptidomimetics in vaccine design.
Riedel T; Ghasparian A; Moehle K; Rusert P; Trkola A; Robinson JA
Chembiochem; 2011 Dec; 12(18):2829-36. PubMed ID: 22076829
[TBL] [Abstract][Full Text] [Related]
8. Protein epitope mimetics as anti-infectives.
Robinson JA
Curr Opin Chem Biol; 2011 Jun; 15(3):379-86. PubMed ID: 21419690
[TBL] [Abstract][Full Text] [Related]
9. A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein A.
Tamborrini M; Geib N; Marrero-Nodarse A; Jud M; Hauser J; Aho C; Lamelas A; Zuniga A; Pluschke G; Ghasparian A; Robinson JA
Vaccines (Basel); 2015 Oct; 3(4):850-74. PubMed ID: 26501327
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics.
Werneburg M; Zerbe K; Juhas M; Bigler L; Stalder U; Kaech A; Ziegler U; Obrecht D; Eberl L; Robinson JA
Chembiochem; 2012 Aug; 13(12):1767-75. PubMed ID: 22807320
[TBL] [Abstract][Full Text] [Related]
11. Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics.
Shankaramma SC; Athanassiou Z; Zerbe O; Moehle K; Mouton C; Bernardini F; Vrijbloed JW; Obrecht D; Robinson JA
Chembiochem; 2002 Nov; 3(11):1126-33. PubMed ID: 12404639
[TBL] [Abstract][Full Text] [Related]
12. The design, structures and therapeutic potential of protein epitope mimetics.
Robinson JA; Demarco S; Gombert F; Moehle K; Obrecht D
Drug Discov Today; 2008 Nov; 13(21-22):944-51. PubMed ID: 18725320
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimicrobial activity against Pseudomonas aeruginosa of macrocyclic β-hairpin peptidomimetic antibiotics containing N-methylated amino acids.
Vetterli SU; Moehle K; Robinson JA
Bioorg Med Chem; 2016 Dec; 24(24):6332-6339. PubMed ID: 27240465
[TBL] [Abstract][Full Text] [Related]
14. Structural studies of β-hairpin peptidomimetic antibiotics that target LptD in Pseudomonas sp.
Schmidt J; Patora-Komisarska K; Moehle K; Obrecht D; Robinson JA
Bioorg Med Chem; 2013 Sep; 21(18):5806-10. PubMed ID: 23932450
[TBL] [Abstract][Full Text] [Related]
15. Exploiting conformationally constrained peptidomimetics and an efficient human-compatible delivery system in synthetic vaccine design.
Moreno R; Jiang L; Moehle K; Zurbriggen R; Glück R; Robinson JA; Pluschke G
Chembiochem; 2001 Nov; 2(11):838-43. PubMed ID: 11948870
[TBL] [Abstract][Full Text] [Related]
16. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa.
Srinivas N; Jetter P; Ueberbacher BJ; Werneburg M; Zerbe K; Steinmann J; Van der Meijden B; Bernardini F; Lederer A; Dias RL; Misson PE; Henze H; Zumbrunn J; Gombert FO; Obrecht D; Hunziker P; Schauer S; Ziegler U; Käch A; Eberl L; Riedel K; DeMarco SJ; Robinson JA
Science; 2010 Feb; 327(5968):1010-3. PubMed ID: 20167788
[TBL] [Abstract][Full Text] [Related]
17. Protein ligand design: from phage display to synthetic protein epitope mimetics in human antibody Fc-binding peptidomimetics.
Dias RL; Fasan R; Moehle K; Renard A; Obrecht D; Robinson JA
J Am Chem Soc; 2006 Mar; 128(8):2726-32. PubMed ID: 16492060
[TBL] [Abstract][Full Text] [Related]
18.
Lin S; Wade JD; Liu S
Acc Chem Res; 2021 Jan; 54(1):104-119. PubMed ID: 33346639
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive peptidomimetic libraries targeting protein-protein interactions.
Whitby LR; Boger DL
Acc Chem Res; 2012 Oct; 45(10):1698-709. PubMed ID: 22799570
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the receptor binding domains of Pseudomonas aeruginosa pili strains PAK, PAO, KB7 and P1 to a cross-reactive antibody and receptor analog: implications for synthetic vaccine design.
Campbell AP; Wong WY; Houston M; Schweizer F; Cachia PJ; Irvin RT; Hindsgaul O; Hodges RS; Sykes BD
J Mol Biol; 1997 Mar; 267(2):382-402. PubMed ID: 9096233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
